Clinical Trials

106 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06709859 2025-07-17

Afatinib Combined With Chemotherapy as Conversion Therapy in Unresectable EGFR Sensitive Mutation-positive Stage III NSCLC

30 enrolled

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06971406 2025-05-14

FLAME-1

100 enrolled

CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06249854 2024-10-01

Efficacy and Safety of Combination Therapy With Bojungikki-tang and Pembrolizumab Monotherapy in Patients With Advanced Non-small Cell Lung Cancer

70 enrolled

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06618391 2024-10-01

Local Injection and Systemic Therapy in the Treatment of NSCLC.

84 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05878028 2024-05-23

L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC

33 enrolled

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05805631 2024-05-01

Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC

23 enrolled

CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

132 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT05377658 2024-02-21

AK104 With Chemotherapy as Neoadjuvant and Adjuvant Therapy for Resectable Non-small Cell Lung Cancer

43 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03446547 2023-11-14

ASTEROID

106 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04074993 2023-09-28

Brigatinib in ALK-positive NSCLC Identified Via Blood-based Assays

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05675033 2023-01-09

Serplulimab Combined With Anti-VEGF Antibody in Advanced Lung Adenocarcinoma

50 enrolled

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung

NCT01003964 2022-04-12

Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV

289 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01156545 2022-04-06

BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC

68 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01470716 2022-04-06

Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations

26 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03612154 2022-04-06

Study of Lorlatinib in ROS1 Rearranged NSCLC

35 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03808480 2022-04-06

Nivolumab After Cyclophosphamide and Doxorubicin Induction Therapy in NSCLC With PD-L1<10%

22 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05252091 2022-02-23

An Exploratory Study of Herombopag for Thrombocytopenia Induced by Chemotherapy Combined With Immunotherapy in NSCLC

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04613804 2020-11-03

Toripalimab as Maintenance Therapy in Patients With Driver-gene Negative Advanced NSCLC After First-line Chemotherapy

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04102982 2020-11-02

MWA in NSCLC

200 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01788332 2018-10-26

PIN

70 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03341494 2017-11-14

EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide

128 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01356368 2014-01-22

Customizing

Phase 2 Terminated

3 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01502202 2012-06-20

Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

162 enrolled

Adenocarcinoma of Lung, Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT00452881 2010-10-25

Adjuvant Gemcitabine Plus Oxaliplatin Versus Gemcitabine Plus Cisplatin for Completely Resected Stage IB/II/IIIA NSCLC

151 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00453115 2010-10-25

Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

43 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00452803 2010-07-12

Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)

102 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01048645 2010-01-13

Effect of All-trans Retinoic Acid With Chemotherapy Based in Paclitaxel and Cisplatin as First Line Treatment of Patients With Advanced Non-small Cell Lung Cancer

107 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01037998 2009-12-23

UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer

115 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

NCT00425022 2007-01-30

VATS Lobectomy for Clinical Stage IB or II Lung Cancer

40 enrolled